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Background: Genomic imbalances constitute a major cause of congenital and developmental abnormalities.
GLUT1 deficiency syndrome is caused by various de novo mutations in the facilitated human glucose transporter 1
gene (1p34.2) and patients with this syndrome have been diagnosed with hypoglycorrhachia, mental and
developmental delay, microcephaly and seizures. Furthermore, 1q terminal deletions have been submitted in the
recent reports and the absence of corpus callosum has been related to the deletion between C1orf100 and
C1orf121 in 1q44.
Results: This study reports on a sibling pair with developmental delay, mental retardation, microcephaly,
hypotonia, epilepsy, facial dysmorphism, ataxia and impaired speech. Chromosome analysis revealed a derivative
chromosome 1 in both patients. FISH and MCB analysis showed two interstitial deletions at 1p34.2 and 1q44. SNP
array and array-CGH analysis also determined the sizes of deletions detailed. The deleted region on 1p34.2
encompasses 33 genes, among which is GLUT1 gene (SLC2A1). However, the deleted region on 1q44 includes
59 genes and distal-proximal breakpoints were located in the ZNF672 gene and SMYD3 gene, respectively.
Conclusion: Haploinsufficiency of GLUT1 leads to GLUT1 deficiency syndrome, consistent with the phenotype in
patients of this study. Conversely, in the deleted region on 1q44, none of the genes are related to findings in
these patients. Additionally, the results confirm previous reports on that corpus callosal development may depend
on the critical gene(s) lying in 1q44 proximal to the SMYD3 gene.
Background
Mental retardation (MR) affects around 3% of the popu-
lation [1,2]. Genomic imbalances constitute a major
cause of congenital and developmental abnormality.
Chromosomal abnormalities are reported in 30-40% of
patients with moderate/severe MR and in 10-15% of
patients with mild MR [3], while submicroscopic subte-
lomeric chromosomal rearrangements may account for
as high as 6.8-7.4% of patients with moderate-severe
MR and for 0.5-1.1% of patients with mild MR [3].
Chromosomal changes cause phenotypic findings
depending on the size and content of the genomic
imbalance. Current data on deletions of 1p34.3p34.1
indicate that these cause minor anomalies, hyperactivity
and severe developmental delay [4,5]. GLUT1 gene
located in this region has recently appeared to cause a
specific syndrome with drug-resistant epilepsy, develop-
mental delay, microcephaly, spasticity, ataxia [5].
Microscopically visible terminal deletions of 1q lead to
a recognizable phenotype with mental retardation,
microcephaly, growth retardation and characteristic
facial features [6]. Various midline abnormalities, parti-
cularly absence of corpus callosum, were reported in
1qter deletions [6]. Recent reports suggested that
absence of corpus callosum was related to deletions
between the genes C1orf100 and C1orf121 in 1q44 [7].
Routine cytogenetics detects chromosomal imbalances
of at least 3-5 Mb in size, limited to resolution of GTG-
banding at 450-600 bands [8]. In the last two decades,
traditional banding has been combined with targeted
molecular technologies in order to improve the resolu-
tion of cytogenetic techniques. Precise delineation of
submicroscopic rearrangements may allow identification
of responsible genes for some clinical features [7].
Array-CGH and SNP oligonucleotide array analysis
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imbalances and genes that possibly contribute to the
clinical findings of the patients may be identified.
We present clinical findings of a sibling pair with
1p34.2 and 1q44 deletions. The data are compared with
previously reported patients having similar chromosomal
abnormalities and genes that possibly contribute to the




The patient is a 10.5-year-old son of healthy nonconsan-
guineous parents. He was born at 38 weeks of gestational
age with a birth weight of 1950 g. His development was
normal until 10 months of age; however, there was delay
in sitting without support until 1.5 years of age. He
walked after 2 years of age and he never talked. Epilepsy
was diagnosed at 7 years of age. He received special edu-
cation for three years, but his mental status never
improved.
On physical examination, weight (24 kg) and height
(126 cm) were both between 3rd-10th centiles, and head
circumference (48.5 cm) was below 3rd centile. He had
deeply-set eyes, large mouth with full lips and widely
spaced teeth, and prognathism (Figure 1). He had ataxia
and was unable to walk independently. Clinical features
of patients are summarized in Table 1.
Stanford-Binet scale of intelligence, performed at
4 years and three months of age, revealed an IQ of 36.
A previous cranial MRI revealed diffuse cerebral atrophy
with a relatively normal sized corpus callosum, relatively
large lateral ventricles and normal sized brain stem and
cerebellum (Figure 2). Ophthalmologic and cardiac
examinations were normal.
As GLUT1 deficiency syndrome was suspected after
completion of the SNP oligonucleotide array analyses,
lumbar puncture was performed following a period of
6 hours fasting, to detect the presence of hypoglycorra-
chia. Blood glucose was 83 mg/dl (70-110), while simul-
taneous CSF glucose was 43 mg/dl (40-80). CSF lactate
was 16.2 mg/dl (9.91-20.72) and no cells were present in
the CSF. CSF/blood glucose ratio was calculated as 0.52,
and considering the clinical picture, was acceptable as
hypoglycorrachia. Ketogenic diet was initiated.
Case B
The patient was the 9-year-old sister of the first patient
who was born at term with a birth weight of 3000 g.
Her development was normal until 10 months of age;
however, there was a delay in sitting without support
until 1 years of age. She walked at three years of age
and she never talked. She had her first convulsive attack
at the age of three months and epilepsy was diagnosed
at the age of six years. She had special education since
5 years of age with no improvement at all. She had diffi-
culty in swallowing and she had ataxia.
On physical examination, she weighed 26 kg (25th-
50th centiles). Her height was 120 cm (3rd-10th cen-
tiles) and her head circumference was 50.5 cm (25th
centile). She had deeply set eyes, large mouth, full lips,
widely spaced teeth and prognathism (Figure 1). She
had ataxia and was unable to walk independently.
Denver Developmental Screening Test was performed
at the age of 2 years and 8 months, which revealed
delay in all four categories. A previous cranial MRI
revealed diffusely atrophic brain with a relatively normal
sized corpus callosum, relatively large lateral ventricles
and normal sized brain stem and cerebellum. Overall,
cerebral atrophy was more severe than in her brother.
Ophthalmologic and cardiac examinations were normal.
Lumbar puncture for detection of hypoglycorrachia
could not be performed because of the presence of
scoliosis.
Written informed consents were obtained from the
patient’s parents for publication of these cases reports
and accompanying images. A copy of the written con-
sent is available for review by the Editor-in-Chief of this
journal.
Methods
Cytogenetic analyses were performed on GTG-banded
metaphase spreads prepared from phytohemagglutinine
(PHA)-stimulated peripheral blood lymphocytes and
chromosome preparation techniques. The karyotypes
were described in accordance with ISCN [9]. Chromo-
some analyses were done in 50 metaphases for each
sample with a resolution of 550 bands.
Whole chromosome painting for chromosome 1 was
done using commercially available probes (Vysis®,
Abbott Laboratories) according to manufacturer’s
instructions. Subtelomeric FISH analyses for 1q were
done applying the corresponding commercially available
probes (Vysis®, Abbott Laboratories). Multicolor chro-
mosome banding (MCB) for chromosome 1 was done as
described previously [10].
Genomic DNA of 250 ng from a sample of previously
isolated genomic DNA was used. Affymetrix 500 K
Assay Protocol and GeneChip® Human Mapping 250 K
Nsp Arrays were used for Genotyping (Affymetrix Inc.
Santa Clara CA, USA) at Hacettepe University School of
Medicine. QC analysis were performed using Affyme-
trix’s software GCOS (Gene Chip Operating Software).
Genotyping Console V2.0 was used for further Copy
Number Variation (CNV) analysis. 50 HapMap 250 K
samples were randomly selected from HapMap Data
Base and used to create a Reference Set for CNV analy-
sis. Furthermore, CNV analysis were then confirmed
using Partek® Genomics Suite v6.3 and CNV regions
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Page 2 of 7Figure 1 Facial appearance of the patients. Note the deeply-set eyes, large mouth with full lips and widely spaced teeth, and prognathism.
Table 1 Clinical findings of patients with 1q deletion
Feature Present patients van Bon et al., 2008 van Bever et al., 2005 de Vries et al., 2001
Karyotype Monosomy 1q44®1qter Monosomy 1q43®q44 Monosomy 1q43®q44 Monosomy 1q43®qter
Low birth weight +/- 8/11 + +
Microcephaly +/+ 11/11 + +
Short stature -/- 10/11 + +
Hypotonia +/+ 10/11 ? +
Mental retardation +/+ 11/11 + +
Impaired speech +/+ 10/11 + +
Motor delay +/+ 10/11 + +
Epilepsy +/+ 9/11 + +
Deep set eyes +/+ 10/11 + +
Widely spaced teeth +/+ 8/11 + ?
Thin bow shaped upper lip +/+ 11/11 + +
Abnormality of corpus callosum -/- 9/11 + +
Scoliosis -/+ 2/11 + +
Ataxia +/+ 0/11 - -
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Page 3 of 7Figure 2 Cranial MRI showing diffuse cerebral atrophy with a relatively normal sized corpus callosum, relatively large lateral
ventricules and normal sized brain stem and cerebellum.
Figure 3 Karyotype of patients showing in (A), FISH with whole chromosome paint 1 exclude the posibility of the missing material
elsewhere in the genome (B) and subtelomeric FISH presenting in (C). Multicolor chromosome banding for Patient 1 clearly shows an
extremely altered pattern on the derivative chromosome 1 (D). Using additional microdissection derived probes (MD45: stains 1pter-1p36.2,
1p35-1p33 and 1p22, MD50: stains 1q42-qter) in combination with a subtelomeric probe for chromosome 1qter (ST1q) or a partial chromosome
paint for the long arm of chromosome 1 (pcp 1q) are shown in figure parts E and F, respectively (E-F). To control the results of array-CGH BAC
RP11-960C20 in 1p34.2 was applied and confirmed deletion of the corresponding region on the derivatve chromosome 1. Thus, the derivative
chromosome 1 could be described as der(1)(pter->p34.2::q43~44->p34.2:) (G).
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onto Database to determine which genes are involved in
those regions.
Array-CGH analysis was performed according to the
manufacturere’s protocol (Agilent, Technologies, Santa
Clara, CA). The investigation was made using a female
genomic DNA pool as reference. The quality of the
experiment was evaluated with the QC metric provided
by the CGH analysis software (CGH Analytics 3.5.14,
Agilent Technologies).
Results
GTG-banded cytogenetic analysis at 550 band resolution
revealed a derivative chromosome 1. The karyotypes of
the siblings were described as 46,XY, der(1)(pter->p34.2::
q43~44->p34.2:) and 46,XX, der(1)(pter->p34.2::q43~44-
>p34.2:) (Figure 3). FISH analysis using WCP probe
excluded the possibility of a translocated material else-
where in the genome. Using subtelomeric probes, FISH
analysis for chromosome 1 showed the deletion on 1q44.
Furthermore, MCB analysis [11] demonstrated the pre-
sence of deletion at 1p34.2 and 1q43~44 (Figure 3).
Cytogenetic studies from the parents showed that the
paternal karyotype was normal. However, the maternal
karyotype was similar. Subtelomeric FISH analysis
showed the deletion on 1q44 in healthy women. But, no
deletion on 1p34.2 was found using array-CGH and
SNP array analysis in this mother.
Using SNP array, an interstitial deletion of 2.9 Mb
in segment 1p34.2 (40430036-43332174 bp) and
2.7 Mb in segment 1q44 (244444664-247110269 bp)
were detected in patients. Additionally, array-CGH
analysis was also performed and deletions in 1p34.2
and 1q44 were presented. In these regions, a number
of deleted genes were observed http://www.ensembl.
org/index.html as shown in Figure 4. At 1p34.2, distal
breakpoint was located in the RLF gene and proximal
breakpoint was in SLC2A1 gene. However, at 1q44,
distal breakpoint of 1q44 was located in ZNF672 gene
and proximal breakpoint was located in SMYD3 gene
(Figure 4).
Discussion
The present sibling pair with interstitial deletions of
1p34.2 and 1q44 supports two previous findings on 1q
and 1p deletions. First, we confirm that haploinsuffi-
ciency of GLUT1 may lead to GLUT1 deficiency syn-
drome in interstitial deletions of 1p34.2, which was
previously described in patients with GLUT1 mutations
[12]. Second, our findings support that absence of corpus
callosum is related to deletions of a short segment of 300
kb between the genes C1orf100 and C1orf121 in 1q44 [7].
Figure 4 Array-CGH analysis presents the deletion on 1p34.2 and 1q44. Schematic representation showing the known genes with the
deleted region. An ideogram of chromosome 1 is shown on top. The region of the short arm from band 1p34.2 (on the left) and the region of
the long arm from band 1q44 (on the right) are enlarged below. The names of known genes and their relative functions are indicated by the
different colors http://www.ensembl.org/index.html.
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1p34.2 must be ruled out in patients presenting with a
clinical picture of GLUT1 deficiency syndrome, which is
characterized by epilepsy, developmental delay, micro-
cephaly, hypotonia, ataxia and impaired speech. In the
presented patients, the deletion in 1p34.2 required high-
resolution analysis to visualize the abnormality. With
increasing use of SNP-array in the clinical area, descrip-
tions of additional patients will allow more precise syn-
drome delineation.
To date, only twenty-three submicroscopic 1q term-
inal deletions have been submitted of which nine were
interstitial [7,13-15]. Our findings show that absence of
corpus callosum is not a clinical finding in deletions
involving the region distal to SMYD3 gene, confirming
t h ep r e v i o u sf i n d i n g s[ 7 ] .F urther identification of
the four genes lying in this region, C1orf100, ADSS,
C1orf101 and C1orf121 and delineation of their func-
tions will clarify the unknown mechanisms in formation
of corpus callosum.
Further examinations of the genes at 1p34.2 and at
1q44 are likely to reveal dosage-sensitive genes that may
contribute to many of these phenotypes. In the pre-
sented patients, 33 genes are located in the deleted
region at 1p34.2 (Figure 4), of which 19 have been pre-
viously described in OMIM database. So far, only seven
(ZMPSTE24, COL9A2, LEPRE1, KCNQ4, CLDN19,
SCL2A1) have been associated with well-known dis-
orders (see Table S1; Additional File 1). Among these,
GLUT1 (SCL2A1) gene seemed to be related to the phe-
notype of our siblings. On the other hand, 59 genes are
l o c a t e di nt h ed e l e t e dr e g i o na t1 q 4 4( F i g u r e4 ) ,o f
which 5 are described in OMIM database and only two
(SMYD3, OR13G1) have been associated with a disease
(see Table S1; Additional File 1). Based on the presented
data of patients and healthy mother, a deletion at 1q44
was not contribute to clinical phenotypes and we
assume that haploinsufficiency of GLUT1 was responsi-
ble for the neurological findings of our patients.
Conclusion
We conclude that molecular characterization of geno-
mic imbalances in patients with developmental retarda-
tion will clarify many unknown aspects of human
development, as suggested by the already accumulated
data. Haploinsufficiency of GLUT1 due to deletions of
1p34.2 leads to GLUT1 deficiency syndrome which
may be a clinically recognizable condition in dys-
morphic patients. Corpus callosal development seems
to be very much dependent on the critical gene(s)
lying in a short segment of 300 kb between the genes
C1orf100 and C1orf121 in 1q44, and not distal to this
region.
Additional file 1: Table S1. The results of SNP array analysis.
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